ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,573Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 117

$1.93M Total Retail Price of All Prescriptions

Rank: 7 out of 117

895 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 895 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

32% of this provider’s 895 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 29,913 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,824 1,622 S3 1 3
LEVOTHYROXINE SODIUM 1,378 1,261 2 1
SIMVASTATIN 1,219 1,077 3 2
FUROSEMIDE 1,203 1,108 4 4
POTASSIUM CHLORIDE 1,195 1,053 5 11
NAMENDA 865 855 6 7
WARFARIN SODIUM 859 811 7 13
LISINOPRIL 755 692 8 6
AMLODIPINE BESYLATE 736 651 9 5
DONEPEZIL HCL 680 677 10 10
OMEPRAZOLE 637 591 11 9
METOPROLOL TARTRATE 621 581 12 8
SERTRALINE HCL 620 574 13 16
LANTUS 576 483 14 25
CITALOPRAM HBR 527 479 15 18
GABAPENTIN 522 471 16 12
MIRTAZAPINE 489 476 17 14
METFORMIN HCL 400 354 18 15
CLOPIDOGREL 356 341 19 30
ZOLPIDEM TARTRATE 356 310 19 24
CARVEDILOL 333 300 21 22
DIGOXIN 326 325 22 45
BUSPIRONE HCL 323 299 23 105
METOPROLOL SUCCINATE 323 284 23 17
ESCITALOPRAM OXALATE 270 235 25 29
CYMBALTA 267 226 26 27
PANTOPRAZOLE SODIUM 265 254 27 39
DIVALPROEX SODIUM 248 227 28 37
QUETIAPINE FUMARATE 243 214 29 20
HYDROCHLOROTHIAZIDE 239 211 30 28
TAMSULOSIN HCL 238 213 31 31
NOVOLOG 236 194 32 60
ALENDRONATE SODIUM 220 213 33 26
TRAMADOL HCL 219 172 34 19
ATORVASTATIN CALCIUM 219 182 34 21
PLAVIX 218 213 36 41
ISOSORBIDE MONONITRATE ER 214 177 37 48
OLANZAPINE 211 161 38 67
PROMETHAZINE HCL 207 168 R 39 77
LOSARTAN POTASSIUM 196 182 40 32
NOVOLIN R 191 168 41 40
CARBIDOPA-LEVODOPA 190 186 42 53
RAMIPRIL 188 188 43 63
GLIPIZIDE 178 159 44 51
IPRATROPIUM-ALBUTEROL 173 166 45 59
ATENOLOL 164 160 46 42
DIOVAN 158 139 47 38
SPIRONOLACTONE 158 135 47 69
RANITIDINE HCL 152 135 49 43
NEXIUM 151 130 50 36
RISPERIDONE 146 91 51 35
ADVAIR DISKUS 146 108 51 71
PREDNISONE 139 136 53 47
LEVETIRACETAM 139 83 53 46
ALBUTEROL SULFATE 137 135 55 68
TRIAMTERENE-HCTZ 135 123 56 94
TRAZODONE HCL 131 109 57 23
PRAVASTATIN SODIUM 130 121 58 33
KLOR-CON M20 125 107 59 54
LIDODERM 119 113 60 62
POLYETHYLENE GLYCOL 3350 118 112 61 61
EXELON 110 110 62 34
HYDRALAZINE HCL 107 103 63 50
PAROXETINE HCL 107 96 63 82
NYSTATIN 107 105 63 81
FLUTICASONE PROPIONATE 107 89 63 44
SPIRIVA 104 94 67 80
CIPROFLOXACIN HCL 103 100 68 56
AZITHROMYCIN 103 97 68 64
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 90 70 79
DILTIAZEM 24HR CD 102 101 70 133
MELOXICAM 99 69 72 70
FINASTERIDE 98 90 73 111
HALOPERIDOL 96 91 74 154
LIDOCAINE HCL 95 92 75 125
LEXAPRO 94 85 76 86
CEPHALEXIN 94 90 76 123
AMIODARONE HCL 93 93 78 98
ROPINIROLE HCL 90 86 79 89
GLIMEPIRIDE 86 82 80 87
SEROQUEL 85 73 81 57
SINGULAIR 83 74 82 99
LOVASTATIN 82 82 83 92
BENZTROPINE MESYLATE 82 35 R 83 97
FENTANYL 82 77 S2 83 103
LYRICA 82 70 83 73
FAMOTIDINE 81 69 87 49
HYDROXYZINE HCL 80 59 R 88 175
PHENYTOIN SODIUM EXTENDED 80 40 88 96
TRIAMCINOLONE ACETONIDE 78 72 90 145
LEVOFLOXACIN 77 71 91 55
CLONIDINE HCL 76 63 92 52
ALLOPURINOL 76 60 92 66
CRESTOR 76 65 92 58
LATANOPROST 76 58 92 84
CYCLOBENZAPRINE HCL 69 64 R 96 110
PROAIR HFA 68 65 97 151
KLOR-CON 10 67 63 98 229
HUMALOG 67 59 98 137
PATANOL 64 60 100 112
HUMULIN R 64 52 100 109
DILTIAZEM ER 64 64 100 244
CEFTRIAXONE 63 58 103 129
VENLAFAXINE HCL ER 63 45 103 78
DETROL LA 62 62 105 146
NITROSTAT 59 57 106 182
OXYBUTYNIN CHLORIDE ER 59 50 106 85
FLUCONAZOLE 59 53 106 198
NITROFURANTOIN MONO-MACRO 58 46 109 100
CLONIDINE 58 34 109 136
NITROFURANTOIN 58 50 109 148
TRAVATAN Z 57 49 112 104
FLUOXETINE HCL 57 49 112 95
BENAZEPRIL HCL 55 46 114 142
KETOCONAZOLE 54 44 115 256
SYMBICORT 54 53 115 205
CELEBREX 51 48 117 134
HYDROCORTISONE 50 40 118 268
NASONEX 50 46 118 257
VERAPAMIL ER 50 32 118 213
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 21, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.